These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28411859)

  • 1. CD14 Plays a Protective Role in Experimental Inflammatory Bowel Disease by Enhancing Intestinal Barrier Function.
    Buchheister S; Buettner M; Basic M; Noack A; Breves G; Buchen B; Keubler LM; Becker C; Bleich A
    Am J Pathol; 2017 May; 187(5):1106-1120. PubMed ID: 28411859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis.
    Su L; Nalle SC; Shen L; Turner ES; Singh G; Breskin LA; Khramtsova EA; Khramtsova G; Tsai PY; Fu YX; Abraham C; Turner JR
    Gastroenterology; 2013 Aug; 145(2):407-15. PubMed ID: 23619146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.
    Nighot P; Al-Sadi R; Rawat M; Guo S; Watterson DM; Ma T
    Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G988-97. PubMed ID: 26514773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice.
    Zhao H; Zhang H; Wu H; Li H; Liu L; Guo J; Li C; Shih DQ; Zhang X
    BMC Gastroenterol; 2012 May; 12():57. PubMed ID: 22647055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-Depth Study of Transmembrane Mucins in Association with Intestinal Barrier Dysfunction During the Course of T Cell Transfer and DSS-Induced Colitis.
    Breugelmans T; Van Spaendonk H; De Man JG; De Schepper HU; Jauregui-Amezaga A; Macken E; Lindén SK; Pintelon I; Timmermans JP; De Winter BY; Smet A
    J Crohns Colitis; 2020 Jul; 14(7):974-994. PubMed ID: 32003421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DHA protects against experimental colitis in IL-10-deficient mice associated with the modulation of intestinal epithelial barrier function.
    Zhao J; Shi P; Sun Y; Sun J; Dong JN; Wang HG; Zuo LG; Gong JF; Li Y; Gu LL; Li N; Li JS; Zhu WM
    Br J Nutr; 2015 Jul; 114(2):181-8. PubMed ID: 26104043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin ameliorates intestinal barrier dysfunction in experimental colitis by inhibiting the activation of nuclear factor-kappa B.
    Cheng J; Zhang L; Dai W; Mao Y; Li S; Wang J; Li H; Guo C; Fan X
    Biochem Biophys Res Commun; 2015 Feb; 458(1):140-7. PubMed ID: 25634696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression.
    Shah YM; Ma X; Morimura K; Kim I; Gonzalez FJ
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1114-22. PubMed ID: 17170021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-18 facilitates neutrophil transmigration via myosin light chain kinase-dependent disruption of occludin, without altering epithelial permeability.
    Lapointe TK; Buret AG
    Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G343-51. PubMed ID: 22135309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological activation of ERβ by arctigenin maintains the integrity of intestinal epithelial barrier in inflammatory bowel diseases.
    Tao Y; Yue M; Lv C; Yun X; Qiao S; Fang Y; Wei Z; Xia Y; Dai Y
    FASEB J; 2020 Feb; 34(2):3069-3090. PubMed ID: 31908053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Par-3 modulates intestinal epithelial barrier function through regulating intracellular trafficking of occludin and myosin light chain phosphorylation.
    Yu M; Yang S; Qiu Y; Chen G; Wang W; Xu C; Cai W; Sun L; Xiao W; Yang H
    J Gastroenterol; 2015 Nov; 50(11):1103-13. PubMed ID: 25820151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-Dihydroxyvitamin D Protects Intestinal Epithelial Barrier by Regulating the Myosin Light Chain Kinase Signaling Pathway.
    Du J; Chen Y; Shi Y; Liu T; Cao Y; Tang Y; Ge X; Nie H; Zheng C; Li YC
    Inflamm Bowel Dis; 2015 Nov; 21(11):2495-506. PubMed ID: 26287999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation.
    Garg A; Zhao A; Erickson SL; Mukherjee S; Lau AJ; Alston L; Chang TK; Mani S; Hirota SA
    J Pharmacol Exp Ther; 2016 Oct; 359(1):91-101. PubMed ID: 27440420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fermented barley and soybean (BS) mixture enhances intestinal barrier function in dextran sulfate sodium (DSS)-induced colitis mouse model.
    Woo JK; Choi S; Kang JH; Kim DE; Hurh BS; Jeon JE; Kim SY; Oh SH
    BMC Complement Altern Med; 2016 Dec; 16(1):498. PubMed ID: 27912750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial-derived neurotrophic factor regulates intestinal epithelial barrier function and inflammation and is therapeutic for murine colitis.
    Zhang DK; He FQ; Li TK; Pang XH; Cui DJ; Xie Q; Huang XL; Gan HT
    J Pathol; 2010 Oct; 222(2):213-22. PubMed ID: 20632386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-146b improves intestinal injury in mouse colitis by activating nuclear factor-κB and improving epithelial barrier function.
    Nata T; Fujiya M; Ueno N; Moriichi K; Konishi H; Tanabe H; Ohtake T; Ikuta K; Kohgo Y
    J Gene Med; 2013; 15(6-7):249-60. PubMed ID: 23813877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-interacting protein modulates colitis susceptibility in mice.
    Maillard MH; Bega H; Uhlig HH; Barnich N; Grandjean T; Chamaillard M; Michetti P; Velin D
    Inflamm Bowel Dis; 2014 Apr; 20(4):660-70. PubMed ID: 24572204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.
    Conlin VS; Wu X; Nguyen C; Dai C; Vallance BA; Buchan AM; Boyer L; Jacobson K
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G735-50. PubMed ID: 19661153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cd14, Gbp1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analyses.
    de Buhr MF; Mähler M; Geffers R; Hansen W; Westendorf AM; Lauber J; Buer J; Schlegelberger B; Hedrich HJ; Bleich A
    Physiol Genomics; 2006 May; 25(3):426-34. PubMed ID: 16705022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.